Literature DB >> 305541

Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia.

L B Vogler, W M Crist, D E Bockman, E R Pearl, A R Lawton, M D Cooper.   

Abstract

Large lymphoid cells containing small amounts of cytoplasmic IgM (clgM) but undetectable surface immunoglobulin (slg) have recently been recognized as precursors of B lymphocytes. They are a small, rapidly dividing pool of normal marrow lymphoblasts. Since lymphoblasts in most childhood acute lymphoblastic leukemias lack slg and other conventional B-lymphocyte and T-lymphocyte markers, we examined the possibility that some leukemias represent "pre-B"-cell neoplasms. In four of 22 consecutive patients, leukemic cells had the clgM+.slg- phenotype of pre-B cells. These patients' cells shared "common acute-lymphoblastic-leukemia" antigens and "B-cell" alloantigens, but differed in expression of several developmental features characteristic of the B-cell line. Pre-B-cell leukemias were readily responsive to chemotherapy. We conclude that a distinct subpopulation of previously unclassified leukemias reflects oncogenic transformation at the earliest recognizable stage in differentiation along the B-cell axis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 305541     DOI: 10.1056/NEJM197804202981603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  59 in total

1.  Establishment and characterization of new B-cell precursor leukemia cell line NALM-35.

Authors:  Yoshinobu Matsuo; Hans G Drexler; Akira Harashima; Nobuharu Fujii; Fumihiko Ishimaru; Kunzo Orita
Journal:  Hum Cell       Date:  2002-12       Impact factor: 4.174

Review 2.  B lymphocytes: how they develop and function.

Authors:  Tucker W LeBien; Thomas F Tedder
Journal:  Blood       Date:  2008-09-01       Impact factor: 22.113

3.  Normal pre-B cells express a receptor complex of mu heavy chains and surrogate light-chain proteins.

Authors:  N Nishimoto; H Kubagawa; T Ohno; G L Gartland; A K Stankovic; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

4.  Discordance between surface and cytoplasmic expression of the Leu-4 (T3) antigen in thymocytes and in blast cells from childhood T lymphoblastic malignancies.

Authors:  M P Link; S J Stewart; R A Warnke; R Levy
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  Immunoglobulin mu-chain gene rearrangement in a patient with T cell acute lymphoblastic leukemia.

Authors:  K Ha; M Minden; N Hozumi; E W Gelfand
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

6.  Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.

Authors:  R Foa; N Migone; M Saitta; M T Fierro; M C Giubellino; P Lusso; L Cordero di Montezemolo; R Miniero; F Lauria
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

7.  B-cell lymphoblastic leukemia in a 30-year-old male with back pain and thrombocytopenia.

Authors:  Emilia Calvaresi; Syed Anwaruddin; Krishnarao Tangella; Janet Jokela
Journal:  Carle Sel Pap       Date:  2017

8.  A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies.

Authors:  R Levy; J Dilley; R I Fox; R Warnke
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

9.  B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.

Authors:  L M Nadler; S J Korsmeyer; K C Anderson; A W Boyd; B Slaughenhoupt; E Park; J Jensen; F Coral; R J Mayer; S E Sallan
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

10.  Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.

Authors:  Valerie I Brown; Junjie Fang; Keith Alcorn; Rosalind Barr; Jenny M Kim; Robert Wasserman; Stephan A Grupp
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.